Richards, A Mark <br/><br/>
B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation.  [electronic resource] 

 -  Evidence-based medicine  Oct 2010 
 - 137-8 p.  digital 
<br/><br/> Publication Type: Comment; Journal Article 
<br/><br/><label>ISSN: </label>1473-6810 
<br/><br/><label>Standard No.: </label>10.1136/ebm1084  doi